CD40LG and breast carcinoma: The ability to differentiate between the adaptive IgM and natural IgM antibodies allows the detection of the early antigens breast cancer in an anticipated (predictive) manner by means of immunoassay, achieving this recognizing regardless of the immunosuppressive environment.